{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:56:49Z","timestamp":1780052209112,"version":"3.53.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02157","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T04:46:48Z","timestamp":1537850808000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Beh\u00e7et Disease"],"prefix":"10.3389","volume":"9","author":[{"given":"Martina","family":"Bonacini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Zerbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Cal\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muratore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Braglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Parmeggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Salvarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Croci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2147\/JMDH.S93681","article-title":"Beh\u00e7et's syndrome: Providing integrated care","volume":"10","author":"Esatoglu","year":"2017","journal-title":"J Multidiscip Healthc"},{"key":"B2","doi-asserted-by":"publisher","first-page":"8867","DOI":"10.1073\/pnas.1406575111","article-title":"Behcet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity","volume":"111","author":"Ombrello","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B3","first-page":"1867","article-title":"Association of MICA alleles and HLA-B51 in Italian patients with Beh\u00e7et's disease","volume":"28","author":"Salvarani","year":"2001","journal-title":"J Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12016-017-8643-2","article-title":"Unmet needs in the pathogenesis and treatment of vasculitides","volume":"54","author":"Muratore","year":"2018","journal-title":"Clin Rev Allergy Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/rheumatology\/keg453","article-title":"The Behcet's disease activity index","volume":"43","author":"Lawton","year":"2004","journal-title":"Rheumatology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/rheumatology\/38.8.728","article-title":"Beh\u00e7et's disease: evaluation of a new instrument to measure clinical activity","volume":"38","author":"Bhakta","year":"1999","journal-title":"Rheumatology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.hemonc.2014.11.006","article-title":"Natural killer cells: In health and disease","volume":"8","author":"Mandal","year":"2015","journal-title":"Hematol Oncol Stem Cell Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/PL00000869","article-title":"CD1d and natural T cells: how their properties jump-start the immune system","volume":"58","author":"Joyce","year":"2001","journal-title":"Cell Mol Life Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fimmu.2011.00018","article-title":"Natural killer cells: from basic research to treatments","volume":"2","author":"Vivier","year":"2011","journal-title":"Front Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"14.37.1","DOI":"10.1002\/0471142735.im1437s110","article-title":"Models to study NK cell biology and possible clinical application","volume":"2015","author":"Zamora","year":"2015","journal-title":"Curr Protoc Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1093\/rheumatology\/keh311","article-title":"Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease","volume":"43","author":"Treusch","year":"2004","journal-title":"Rheumatology"},{"key":"B12","first-page":"588","article-title":"Increased peripheral blood gamma delta+ T cells and natural killer cells in Beh\u00e7et's disease","volume":"19","author":"Suzuki","year":"1992","journal-title":"J Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1365-2249.2004.02536.x","article-title":"The number of CD8+ T cells and NKT cells increases in the aqueous humor of patients with Behcet's uveitis","volume":"137","author":"Yu","year":"2004","journal-title":"Clin Exp Immunol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/bjo.83.12.1386","article-title":"CD56+ T cells in the peripheral blood of uveitis patients","volume":"83","author":"Yato","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/cei.12939","article-title":"Circulating NK cells and their subsets in Beh\u00e7et's disease","volume":"188","author":"Hasan","year":"2017","journal-title":"Clin Exp Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jneuroim.2006.02.011","article-title":"Discrepancies of NKT cells expression in peripheral blood and in cerebrospinal fluid from Beh\u00e7et's disease","volume":"175","author":"Hamzaoui","year":"2006","journal-title":"J Neuroimmunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1158\/2326-6066.CIR-15-0098","article-title":"NKG2D receptor and its ligands in host defense","volume":"3","author":"Lanier","year":"2015","journal-title":"Cancer Immunol Res."},{"key":"B18","first-page":"8","article-title":"NKG2D ligands as therapeutic targets","volume":"13","author":"Spear","year":"2013","journal-title":"Cancer Immun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/cmi.2017.161","article-title":"Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy","volume":"15","author":"Prajapati","year":"2018","journal-title":"Cell Mol Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"21033","DOI":"10.1038\/srep21033","article-title":"Association between functional MICA-TM and Behcet's disease: a systematic review and meta-analysis","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-3083.2006.01780.x","article-title":"Allelic diversity and affinity variants of MICA are imbalanced in Spanish patients with Beh\u00e7et's disease","volume":"64","author":"Mu\u00f1oz-Sa\u00e1","year":"2006","journal-title":"Scand J Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"9452","DOI":"10.1073\/pnas.1632807100","article-title":"Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis","volume":"100","author":"Groh","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B23","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1084\/jem.20081648","article-title":"Normally occurring NKG2D+ CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus","volume":"206","author":"Dai","year":"2009","journal-title":"J Exp Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10067-009-1322-9","article-title":"Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus","volume":"29","author":"Li","year":"2010","journal-title":"Clin Rheumatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/1756-185X.13099","article-title":"Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients","volume":"20","author":"Sourour","year":"2017","journal-title":"Int J Rheum Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/ar4147","article-title":"Expression of regulatory receptors on gammadelta T cells and their cytokine production in Behcet's disease","volume":"15","author":"Parlakgul","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B27","doi-asserted-by":"publisher","first-page":"6133","DOI":"10.4049\/jimmunol.175.9.6133","article-title":"CD8brightCD56+ T cells are cytotoxic effectors in patients with active Behcet's uveitis","volume":"175","author":"Ahn","year":"2005","journal-title":"J Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.imlet.2010.02.005","article-title":"Phenotype markers and cytokine intracellular production by CD8+ \u03b3\u03b4 T lymphocytes do not support a regulatory T profile in Beh\u00e7et's disease patients and healthy controls","volume":"129","author":"Clemente","year":"2010","journal-title":"Immunol Lett."},{"key":"B29","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3389\/fimmu.2017.00930","article-title":"Developmental and functional control of natural killer cells by cytokines","volume":"8","author":"Wu","year":"2017","journal-title":"Front Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1172\/JCI200423594","article-title":"Going both ways: immune regulation via CD1d-dependent NKT cells","volume":"114","author":"Godfrey","year":"2004","journal-title":"J Clin Invest."},{"key":"B31","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4049\/jimmunol.143.4.1206","article-title":"IFN-beta 2\/IL-6 augments the activity of human natural killer cells","volume":"143","author":"Luger","year":"1989","journal-title":"J Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1189\/JLB.71.2.173","article-title":"Role of chemokines in the biology of natural killer cells","volume":"71","author":"Robertson","year":"2002","journal-title":"J Leukoc Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00296-012-2446-9","article-title":"Beh\u00e7et's disease: Immunological relevance with arthritis of ankylosing spondylitis","volume":"33","author":"Aktas","year":"2013","journal-title":"Rheumatol Int."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1167\/iovs.05-0966","article-title":"Elevated serum levels of CXCL9\/monokine induced by interferon-gamma and CXCL10\/interferon-gamma-inducible protein-10 in ocular sarcoidosis","volume":"47","author":"Takeuchi","year":"2006","journal-title":"Invest OphthalmolVisSci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1097\/MD.0000000000001858","article-title":"Putative role of serum amyloid-A and proinflammatory cytokines as biomarkers for Behcet's disease","volume":"94","author":"Lopalco","year":"2015","journal-title":"Medicine"},{"key":"B36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jneuroim.2003.08.040","article-title":"Cytokines and chemokines in neuro-Beh\u00e7et's disease compared to multiple sclerosis and other neurological diseases","volume":"145","author":"Saruhan-Direskeneli","year":"2003","journal-title":"J Neuroimmunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1002\/jcb.26809","article-title":"Hypermethylation of IL-10 gene is responsible for its low mRNA expression in Beh\u00e7et's disease","volume":"119","author":"Alipour","year":"2018","journal-title":"J Cell Biochem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3892\/br.2017.996","article-title":"Aberrant expression of interleukin-10 and activation-induced cytidine deaminase in B cells from patients with Beh\u00e7et's disease","volume":"7","author":"Yoon","year":"2017","journal-title":"Biomed Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcla.21772","article-title":"Serum cytokine levels in Beh\u00e7et's disease","volume":"4","author":"Akkurt","year":"2014","journal-title":"J Clin Lab Anal."},{"key":"B40","first-page":"510","article-title":"Serum levels of Th2 cytokines IL-4 and IL-10 in Beh\u00e7et's disease","volume":"26","author":"Manta\u015f","year":"1999","journal-title":"J Rheumatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1167\/iovs.04-0792","article-title":"Down-regulation of IFN-(gamma)-producing CD56+ T cells after combined low-dose cyclosporine\/prednisone treatment in patients with Behcet's uveitis","volume":"46","author":"Ahn","year":"2005","journal-title":"Investig Ophthalmol Vis Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.imlet.2008.07.009","article-title":"Serum cytokine profiles in Beh\u00e7et's disease: is there a role for IL-15 in pathogenesis?","volume":"121","author":"Curnow","year":"2008","journal-title":"Immunol Lett"},{"key":"B43","first-page":"128","article-title":"Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behcet's disease; soluble TNFR-75 as a biological marker of disease activity","volume":"24","author":"Turan","year":"1997","journal-title":"J Rheumatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/j.1346-8138.2003.tb00442.x","article-title":"Serum levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Beh\u00e7et's disease","volume":"30","author":"Aridogan","year":"2003","journal-title":"J Dermatol."},{"key":"B45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/030097402320318387","article-title":"Cytokine profile in Beh\u00e7et's disease patients. Relationship with disease activity","volume":"31","author":"Hamzaoui","year":"2002","journal-title":"Scand J Rheumatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.semarthrit.2015.11.012","article-title":"Tocilizumab in severe and refractory Behcet's disease: Four cases and literature review","volume":"45","author":"Deroux","year":"2016","journal-title":"Semin Arthritis Rheum."},{"key":"B47","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/jop.12182","article-title":"Serum Th1, Th2 and Th17 cytokine profiles and alpha-enolase levels in recurrent aphthous stomatitis","volume":"43","author":"Ozyurt","year":"2014","journal-title":"J Oral Pathol Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.imlet.2016.12.001","article-title":"An elevated pro-inflammatory cytokines profile in Behcet's disease: A multiplex analysis","volume":"186","author":"Gholijani","year":"2017","journal-title":"Immunol Lett."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1158\/0008-5472.CAN-12-3558","article-title":"A chimeric receptor with NKG2D specificity enhances natural killer cell activation and killing of tumor cells","volume":"73","author":"Chang","year":"2013","journal-title":"Cancer Res."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02157\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T10:40:27Z","timestamp":1693910427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02157\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2018.02157"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02157","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,25]]},"article-number":"2157"}}